RT Journal Article
SR Electronic
T1 Assessing transmission risks and control strategy for monkeypox as an emerging zoonosis in a metropolitan area
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.06.28.22277038
DO 10.1101/2022.06.28.22277038
A1 Pei Yuan
A1 Yi Tan
A1 Liu Yang
A1 Elena Aruffo
A1 Nicholas H. Ogden
A1 Jacques Bélair
A1 Jane Heffernan
A1 Julien Arino
A1 James Watmough
A1 Hélène Carabin
A1 Huaiping Zhu
YR 2022
UL http://medrxiv.org/content/early/2022/06/29/2022.06.28.22277038.abstract
AB Objective To model the spread of Monkeypox (MPX) in a metropolitan area for assessing the risk of possible outbreaks, and identifying essential public health measures to contain the virus spread.Methods The animal reservoir is the key element in the modelling of a zoonotic disease. Using a one health approach, we model the spread of the MPX virus in humans considering animal hosts like rodents (e.g., rats, mice, squirrels, chipmunks, etc.) and emphasize their role and transmission of the virus in a high-risk group, including gay and bisexual men-who-have-sex-with-men (gbMSM). From model and sensitivity analysis, we identify key public health factors and present scenarios under different transmission assumptions.Findings We find that the MPX virus may spill over from gbMSM high-risk groups to broader populations if efficiency of transmission increases in the higher-risk group. However, the risk of outbreak can be greatly reduced if at least 65% of symptomatic cases can be isolated and their contacts traced and quarantined. In addition, infections in an animal reservoir will exacerbate MPX transmission risk in the human population.Conclusion Regions or communities with a higher proportion of gbMSM individuals need greater public health attention. Tracing and quarantine (or “effective quarantine” by post-exposure vaccination) of contacts with MPX cases in high-risk groups would have a significant effect on controlling the spreading. Also, surveillance for animal infections would be prudent.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by the Natural Sciences and Engineering Research Council of Canada OMNI-REUNI network for the Emerging Infectious Disease Modelling Initiative (NSERC EIDM) (NO, JA, JB, JH, JW, H.B., HZ) and by the York Research Chair Program (HZ).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript